Clinical trial Recruiting at 1 site Observational Ages 0 to 18

Evaluating gastrointestinal eosinophilic disorders in children

Official title: National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders

Run by Fondazione IRCCS Policlinico San Matteo di Pavia · NCT05219903 · Data updated 2026-11-12

This study looks at how common eosinophilic gastrointestinal disorders are in children to help improve understanding and treatment of these conditions.

Quick facts

Study typeObservational
Ages0 Years to 18 Years
SexAll
Enrollment300 (estimated)
SponsorFondazione IRCCS Policlinico San Matteo di Pavia
Academic / other
Locations1 site (Pavia)
StatusRecruiting
StartedJanuary 20, 2022
Main results expectedJanuary 31, 2027
Study endsJanuary 31, 2027
Registry record updatedJuly 25, 2024
Trial IDNCT05219903 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 0-18 years diagnosed with eosinophilic gastrointestinal disorders.

Probably not a fit

Patients diagnosed with eosinophilic gastrointestinal disorders more than five years prior or with secondary causes of intestinal eosinophilic inflammation will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the prevalence and incidence of eosinophilic gastrointestinal disorders (EGIDs) in pediatric patients across multiple centers in Italy. It focuses on conditions such as eosinophilic esophagitis, gastritis, gastroenteritis, and colitis, which are increasingly recognized but poorly understood. By collecting data from patients aged 0-18 years, the study seeks to provide clearer epidemiological insights into these disorders and improve diagnostic and therapeutic guidelines. Informed consent will be obtained from patients and their guardians for participation.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management of eosinophilic gastrointestinal disorders in children.

How similar studies have gone: While there have been some retrospective studies on eosinophilic gastrointestinal disorders, this study aims to fill significant gaps in the understanding of non-esophageal forms, making it a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- All EGIDs patients aged 0-18 years and followed at the centers involved in the study will be considered eligible. Informed consent must be obtained from each enrolled patient and signed by a parent/legal guardian and patient (when older than six years).

Exclusion Criteria:

\- This study will not include patients with:

1. a diagnosis of EGIDs made more than five years before the study participation;
2. a diagnosis of EoE not in line with current international guidelines;
3. a secondary cause of intestinal eosinophilic inflammation (inflammatory bowel diseases, autoimmune diseases, vasculitis, graft versus host disease, malignancies).

Where it's running

  • IRCCS Policlinico San Matteo
    Pavia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.